LOL!Hey, most of us don't leave fingerprints.....
Sushi
LOL!Hey, most of us don't leave fingerprints.....
Sushi
It finished Phase II, Phase III is ahead, data will become available in 2015, so if everything runs well, it could become available in 2017.
Say what!!?!!!! 2017!!! (sad face)
Yes, and that's probably on fast-track as well, but I could be wrong.
I'm interested in antivirals myself but haven't had any tests done specifically for viruses, only bacterial infections which I'm treating with antibiotics.
Are there any specific clinical differences between viral CFS/ME and "non-viral", if there is indeed such a thing? In other words, any differences between those who had significant relief from symptoms by using antivirals as opposed to those who haven't used it because they test negative for known viruses?
Yes, and that's probably on fast-track as well, but I could be wrong.
I'm interested in antivirals myself but haven't had any tests done specifically for viruses, only bacterial infections which I'm treating with antibiotics.
Are there any specific clinical differences between viral CFS/ME and "non-viral", if there is indeed such a thing? In other words, any differences between those who had significant relief from symptoms by using antivirals as opposed to those who haven't used it because they test negative for known viruses?
?
Really? But I would assume they are all in the herpes virus family? I would be incredible to have one drug target so many viruses.
CMX001’s potential to be a safe and efficacious broad-spectrum
antiviral for the treatment of double-stranded DNA viral infections,